Ionis Pharmaceuticals, Inc. (IONS)
75.88
-0.46
(-0.60%)
USD |
NASDAQ |
Jan 20, 10:49
Ionis Pharmaceuticals EPS Diluted (Quarterly): -0.805 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Pfizer Inc. | 0.6197 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Biogen, Inc. | 3.171 |
| Cogent Biosciences, Inc. | -0.5884 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -128.61M |
| Revenue (Quarterly) | 156.72M |
| Total Expenses (Quarterly) | 285.32M |
| Enterprise Value | 12.17B |
| Gross Profit Margin (Quarterly) | 96.67% |
| Profit Margin (Quarterly) | -82.06% |
| Earnings Yield | -2.26% |
| Normalized Earnings Yield | -2.308 |